Table 3.
Associations between serum miRNAs and clinical characteristics in pPD patients by Spearman’s rank correlation analysis.
| Variables | miR-31 | miR-214 |
|---|---|---|
| Gender | 0.394 | 0.205 |
| Age | 0.283 | 0.168 |
| UPDRS III | −0.281 | −0.156 |
| NMSQ | 0.087 | −0.073 |
| MMSE | −0.042 | 0.097 |
| MoCA | 0.133 | 0.198 |
| HAMD | 0.120 | −0.114 |
| HAMA | 0.209 | 0.063 |
| RBDQ-HK | 0.240 | 0.312 |
UPDRS, Unified Parkinson’s Disease Rating Scale; NMSQ, Non-Motor Symptoms Questionnaire; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; HAMD, Hamilton Depression Rating Scale; HAMA, Hamilton Anxiety Scale; RBDQ-HK, REM Sleep Behavior Disorder Questionnaire-Hong Kong.